Karuna Garg Selected Research

Adenomatoid Tumor

1/2019	Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42.
1/2018	Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karuna Garg Research Topics

Disease

14	Neoplasms (Cancer) 03/2021 - 10/2004
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 08/2011
6	Leiomyomatosis 01/2021 - 07/2014
5	Leiomyoma (Uterine Fibroids) 01/2019 - 08/2011
4	Smooth Muscle Tumor 01/2021 - 07/2014
4	Endometrial Neoplasms (Endometrial Cancer) 03/2014 - 06/2009
3	Carcinoma (Carcinomatosis) 01/2020 - 10/2004
3	Mesothelioma 01/2019 - 01/2017
2	Adenosarcoma 07/2020 - 01/2019
2	Adenomatoid Tumor 01/2019 - 01/2018
2	Malignant Mesothelioma 01/2019 - 01/2017
2	Cysts 01/2018 - 05/2009
2	Carcinogenesis 01/2017 - 04/2013
2	Endometrioid Carcinoma 11/2013 - 12/2009
1	Fibrosarcoma 07/2020
1	Neoplasm Metastasis (Metastasis) 07/2020
1	Teratoma (Teratoid Tumor) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 07/2017
1	Hereditary Breast and Ovarian Cancer Syndrome 06/2014
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 04/2013
1	Ovarian Neoplasms (Ovarian Cancer) 02/2013
1	Disease Progression 09/2012
1	Carcinosarcoma 12/2011
1	Meigs Syndrome (Meig's Syndrome) 05/2005
1	Breast Neoplasms (Breast Cancer) 10/2004

Drug/Important Bio-Agent (IBA)

6	Fumarate Hydratase (Fumarase)IBA 01/2021 - 07/2014
2	Cadherins (E-Cadherin)IBA 03/2021 - 11/2013
2	Estrogen ReceptorsIBA 01/2021 - 12/2009
2	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 01/2020
2	NF-kappa B (NF-kB)IBA 01/2019 - 01/2018
2	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 12/2009 - 06/2009
1	beta CateninIBA 03/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2020
1	larotrectinibIBA 07/2020
1	Hormones (Hormone)IBA 01/2020
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	Fumaric aciduriaIBA 01/2019
1	Ribonucleases (Ribonuclease)IBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	CarcinogensIBA 01/2017
1	AsbestosIBA 01/2017
1	S-(2-succinyl)cysteineIBA 01/2016
1	Cysteine (L-Cysteine)FDA Link 07/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2014
1	Hematoxylin (Haematoxylon)IBA 07/2014
1	Estrogens (Estrogen)FDA Link 03/2014
1	OsteonectinIBA 11/2013
1	Valine (L-Valine)FDA Link 02/2013
1	Glutamic Acid (Glutamate)FDA Link 02/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2009
1	Calbindin 2IBA 02/2005
1	Keratin-5 (Keratin 5)IBA 02/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2004
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2004
1	Fluorouracil (Carac)FDA LinkGeneric 10/2004
1	TubulinIBA 10/2004
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2004

Therapy/Procedure

5	Therapeutics 07/2020 - 02/2013
3	Hysterectomy 01/2019 - 08/2011
3	Drug Therapy (Chemotherapy) 02/2013 - 10/2004
2	Ovariectomy (Oophorectomy) 04/2013 - 05/2005
1	Radiotherapy 01/2020
1	Uterine Myomectomy 01/2019
1	Salpingectomy 06/2014
1	Cytoreduction Surgical Procedures 12/2011
1	Conservative Treatment 12/2009
1	Cystectomy 05/2009
1	Adjuvant Chemotherapy 10/2004
1	Mastectomy (Mammectomy) 10/2004